
Sign up to save your podcasts
Or


Catherine Otto, Heart's editor in chief, interviews April Stempien-Otero from the University of Washington, at the American Heart Association meeting in Dallas.
They discuss Dr Stempien-Otero's late breaking clinical trial, presented at the meeting, which looks at the use of bone marrow derived stem cells, and their use in ischemic cardiomyopathy with LVAD bridge to transfer.
By BMJ Group4.6
3939 ratings
Catherine Otto, Heart's editor in chief, interviews April Stempien-Otero from the University of Washington, at the American Heart Association meeting in Dallas.
They discuss Dr Stempien-Otero's late breaking clinical trial, presented at the meeting, which looks at the use of bone marrow derived stem cells, and their use in ischemic cardiomyopathy with LVAD bridge to transfer.

135 Listeners

321 Listeners

495 Listeners

170 Listeners

37 Listeners

50 Listeners

5 Listeners

8 Listeners

5 Listeners

3 Listeners

1 Listeners

3 Listeners

8 Listeners

14 Listeners

1 Listeners

50 Listeners

0 Listeners

6 Listeners

888 Listeners

14 Listeners

3 Listeners

3,331 Listeners

3 Listeners

21 Listeners

138 Listeners

1,154 Listeners

196 Listeners

142 Listeners

514 Listeners

24 Listeners

364 Listeners

432 Listeners

233 Listeners